These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
465 related items for PubMed ID: 27271488
1. Long-term Safety and Efficacy of Low-dose Azathioprine and Allopurinol Cotherapy in Inflammatory Bowel Disease: A Large Observational Study. Pavlidis P, Stamoulos P, Abdulrehman A, Kerr P, Bull C, Duley J, Ansari A. Inflamm Bowel Dis; 2016 Jul; 22(7):1639-46. PubMed ID: 27271488 [Abstract] [Full Text] [Related]
2. Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol. Smith MA, Blaker P, Marinaki AM, Anderson SH, Irving PM, Sanderson JD. J Crohns Colitis; 2012 Oct; 6(9):905-12. PubMed ID: 22386736 [Abstract] [Full Text] [Related]
4. Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease. Hoentjen F, Seinen ML, Hanauer SB, de Boer NK, Rubin DT, Bouma G, Harrell LE, van Bodegraven AA. Inflamm Bowel Dis; 2013 Feb; 19(2):363-9. PubMed ID: 22605661 [Abstract] [Full Text] [Related]
5. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients. Wong DR, Pierik M, Seinen ML, van Bodegraven AA, Gilissen LP, Bus P, Bakker JA, Masclee AA, Neef C, Engels LG, Hooymans PM. J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783 [Abstract] [Full Text] [Related]
6. Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease. Andoh A, Tsujikawa T, Ban H, Hashimoto T, Bamba S, Ogawa A, Sasaki M, Saito Y, Fujiyama Y. J Gastroenterol Hepatol; 2008 Sep; 23(9):1373-7. PubMed ID: 18662197 [Abstract] [Full Text] [Related]
7. Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease. Haines ML, Ajlouni Y, Irving PM, Sparrow MP, Rose R, Gearry RB, Gibson PR. Inflamm Bowel Dis; 2011 Jun; 17(6):1301-7. PubMed ID: 20812329 [Abstract] [Full Text] [Related]
8. Randomized clinical trial: a pilot study comparing efficacy of low-dose azathioprine and allopurinol to azathioprine on clinical outcomes in inflammatory bowel disease. Kiszka-Kanowitz M, Theede K, Mertz-Nielsen A. Scand J Gastroenterol; 2016 Dec; 51(12):1470-1475. PubMed ID: 27686002 [Abstract] [Full Text] [Related]
9. Azathioprine with Allopurinol Is a Promising First-Line Therapy for Inflammatory Bowel Diseases. van Liere ELSA, Bayoumy AB, Mulder CJJ, Warner B, Hayee B, Mateen BA, Nolan JD, de Boer NKH, Anderson SHC, Ansari AR. Dig Dis Sci; 2022 Aug; 67(8):4008-4019. PubMed ID: 34729677 [Abstract] [Full Text] [Related]
10. Is there a role for thioguanine therapy in IBD in 2017 and beyond? Taylor KM, Ward MG, Blaker PA, Sparrow MP. Expert Rev Gastroenterol Hepatol; 2017 May; 11(5):473-486. PubMed ID: 28276819 [Abstract] [Full Text] [Related]
11. Combination of thiopurines and allopurinol: adverse events and clinical benefit in IBD. Govani SM, Higgins PD. J Crohns Colitis; 2010 Oct; 4(4):444-9. PubMed ID: 21122542 [Abstract] [Full Text] [Related]
13. Low-dose thiopurine with allopurinol co-therapy overcomes thiopurine intolerance and allows thiopurine continuation in inflammatory bowel disease. Vasudevan A, Beswick L, Friedman AB, Moltzen A, Haridy J, Raghunath A, Sparrow M, van Langenberg D. Dig Liver Dis; 2018 Jul 01; 50(7):682-688. PubMed ID: 29525182 [Abstract] [Full Text] [Related]
14. Body Mass Index and Smoking Affect Thioguanine Nucleotide Levels in Inflammatory Bowel Disease. Poon SS, Asher R, Jackson R, Kneebone A, Collins P, Probert C, Dibb M, Subramanian S. J Crohns Colitis; 2015 Aug 01; 9(8):640-6. PubMed ID: 25968584 [Abstract] [Full Text] [Related]
15. Higher Thioguanine Nucleotide Metabolite Levels are Associated With Better Long-term Outcomes in Patients With Inflammatory Bowel Diseases. Yarur AJ, Gondal B, Hirsch A, Christensen B, Cohen RD, Rubin DT. J Clin Gastroenterol; 2018 Jul 01; 52(6):537-544. PubMed ID: 28723860 [Abstract] [Full Text] [Related]
16. Routinely Established Skewed Thiopurine Metabolism Leads to a Strikingly High Rate of Early Therapeutic Failure in Patients With Inflammatory Bowel Disease. Kreijne JE, Seinen ML, Wilhelm AJ, Bouma G, Mulder CJ, van Bodegraven AA, de Boer NK. Ther Drug Monit; 2015 Dec 01; 37(6):797-804. PubMed ID: 25853923 [Abstract] [Full Text] [Related]
17. Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: the ENTRANCE study. Herrlinger KR, Diculescu M, Fellermann K, Hartmann H, Howaldt S, Nikolov R, Petrov A, Reindl W, Otte JM, Stoynov S, Strauch U, Sturm A, Voiosu R, Ammendola A, Dietrich B, Hentsch B, Stange EF. J Crohns Colitis; 2013 Sep 01; 7(8):636-43. PubMed ID: 23078909 [Abstract] [Full Text] [Related]
18. Azathioprine with Allopurinol: Lower Deoxythioguanosine in DNA and Transcriptome Changes Indicate Mechanistic Differences to Azathioprine Alone. Coulthard SA, Berry P, McGarrity S, McLaughlin S, Ansari A, Redfern CPF. Inflamm Bowel Dis; 2017 Jun 01; 23(6):946-955. PubMed ID: 28452864 [Abstract] [Full Text] [Related]
19. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine. Chatzinasiou F, Polymeros D, Panagiotou M, Theodoropoulos K, Rigopoulos D. Acta Dermatovenerol Croat; 2016 Apr 01; 24(1):83-5. PubMed ID: 27149138 [Abstract] [Full Text] [Related]
20. Outcome of concomitant treatment with thiopurines and allopurinol in patients with inflammatory bowel disease: A nationwide Danish cohort study. Thomsen SB, Allin KH, Burisch J, Jensen CB, Hansen S, Gluud LL, Theede K, Kiszka-Kanowitz M, Nielsen AM, Jess T. United European Gastroenterol J; 2020 Feb 01; 8(1):68-76. PubMed ID: 32213059 [Abstract] [Full Text] [Related] Page: [Next] [New Search]